NewslettersHematopoiesis NewsImpdh Inhibition Activates Tlr-VCAM1 Pathway and Suppresses the Development of Mll-Fusion LeukemiaBy Jamie Kang - December 6, 20220153The authors found that AMLs with MLL-fusions were susceptible to Inosine monophosphate dehydrogenase inhibitors in vitro.[EMBO Molecular Medicine]Full ArticleGraphical Abstract